此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Usefulness of C-reactive Protein Testing in Acute Cough

2013年2月16日 更新者:Northern State Medical University

The Usefulness of Point-of-care-testing for C-reactive Protein in Lower Respiratory Tract Infection or Acute Cough

The aim of this study is to evaluate the usefulness in Russian general practice of C-reactive protein testing in patients with acute cough or lower respiratory tract infections.

In addition to studying the effect of C-reactive protein testing on the prescription of antibiotics, the purpose is to find out whether the frequency of referral to radiography could be reduced.

研究概览

地位

完全的

详细说明

Eighteen general practitioners, from both urban and rural offices, were randomised into intervention and control groups. All registrations were made by general practitioners in their offices.

The case report form was similar to that used in the GRACE study (Genomics to combat Resistance against Antibiotics in Community-acquired lower respiratory tract infections in Europe (www.grace-lrti.org) describing symptoms, findings, and treatment in lower respiratory tract infections.

  • The clinical examination included a chest examination and the axillary temperature.
  • After the clinical examination, the general practitioners recorded their provisional diagnosis.
  • Chest radiography was accessible for all patients.

The C-reactive protein test was performed in the intervention group at both the first and second consultations. The Afinion test system was used, which provides results within 5 minutes and before treatment was determined. This test is based on solid-phase sandwich immunometric analysis.

General practitioners could prescribe any treatment, including antibiotics and other drugs for the cough and additional medication if deemed necessary.

研究类型

介入性

注册 (实际的)

179

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Arkhangelsk、俄罗斯联邦、163000
        • Northern State Medical University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • patients with lower respiratory tract infections/acute cough (including acute bronchitis, pneumonia, and infectious exacerbations of chronic obstructive pulmonary disease or asthma),
  • age 18 years or older,
  • an illness of less than 28 days duration,
  • first consultation for the illness episode,
  • being seen in a physician's office,
  • written consent to participate.

Exclusion Criteria:

  • an inability to fill out study documentation,
  • being previously included in the study,
  • immunocompromised status (HIV patients, immunosuppressive treatment),
  • ongoing treatment with oral corticosteroids

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:C-reactive protein test

The C-reactive protein test was performed in the intervention group at both the first and second consultations.

The Afinion test system (Axis Shield) was used, which provides results within 5 minutes and before treatment was determined. This test is based on solid-phase sandwich immunometric analysis. The measurement range in whole blood samples is 8-200 mg/L.

Results provides within 5 minutes. This test is based on solid-phase sandwich immunometric analysis. The measurement range in whole blood samples is 8-200 mg/L.
其他名称:
  • The Afinion test system (Axis Shield)

研究衡量的是什么?

主要结果指标

结果测量
大体时间
the antibiotic prescribing rate
大体时间:within the first 2 weeks after first consultation
within the first 2 weeks after first consultation

次要结果测量

结果测量
大体时间
referral to radiography
大体时间:within the first 2 weeks after first consultation
within the first 2 weeks after first consultation

其他结果措施

结果测量
措施说明
大体时间
rate of recovery at the follow-up consultation
大体时间:within the first 2 weeks after first consultation
Rate of recovery at the follow-up consultation after 2 weeks with the following five alternatives: "fully recovered", "almost recovered", "slightly improved", "unchanged", and "worse". Consultations with the general practitioner within 2 weeks and complications (in need of hospitalisation) were recorded.
within the first 2 weeks after first consultation

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Hasse Melbye, PhD、University of Tromsø, Department of Community Medicine
  • 首席研究员:Elena A Andreeva, MD, MPH、Northern State Medical University, Family Medicine Department

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年1月1日

初级完成 (实际的)

2010年4月1日

研究完成 (实际的)

2010年4月1日

研究注册日期

首次提交

2013年2月16日

首先提交符合 QC 标准的

2013年2月16日

首次发布 (估计)

2013年2月20日

研究记录更新

最后更新发布 (估计)

2013年2月20日

上次提交的符合 QC 标准的更新

2013年2月16日

最后验证

2013年2月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • CRP-ARK-01/10

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅